RO112991B1
(ro)
*
|
1992-09-18 |
1998-03-30 |
Yamanouchi Pharma Co Ltd |
Preparat tip hidrogel, cu eliberare sustinuta
|
DE19509807A1
(de)
*
|
1995-03-21 |
1996-09-26 |
Basf Ag |
Verfahren zur Herstellung von Wirkstoffzubereitungen in Form einer festen Lösung des Wirkstoffs in einer Polymermatrix sowie mit diesem Verfahren hergestellte Wirkstoffzubereitungen
|
US5945125A
(en)
*
|
1995-02-28 |
1999-08-31 |
Temple University |
Controlled release tablet
|
US6166024A
(en)
*
|
1995-03-30 |
2000-12-26 |
Mayo Foundation For Medical Education And Research |
Use of topical azathioprine and thioguanine to treat colorectal adenomas
|
EP0761209A3
(en)
*
|
1995-09-01 |
1998-02-04 |
J.B. Chemicals & Pharmaceuticals Ltd. |
Controlled release formulations of ranitidine
|
ATE427124T1
(de)
*
|
1996-06-26 |
2009-04-15 |
Univ Texas |
Heiss-geschmolzene extrudierbare pharmazeutische formulierung
|
AU3444297A
(en)
*
|
1996-07-12 |
1998-02-09 |
Novartis Consumer Health S.A. |
Oral pharmaceutical combinations of nsaids with terpenoids
|
GB9720797D0
(en)
*
|
1997-09-30 |
1997-12-03 |
Rhodes John |
Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome
|
US20040029962A1
(en)
*
|
1997-12-12 |
2004-02-12 |
Chih-Ming Chen |
HMG-COA reductase inhibitor extended release formulation
|
US8679534B2
(en)
*
|
1997-12-12 |
2014-03-25 |
Andrx Labs, Llc |
HMG-CoA reductase inhibitor extended release formulation
|
SE9704869D0
(sv)
*
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New pharmaceutical formulaton II
|
DE19901040A1
(de)
*
|
1999-01-14 |
2000-07-20 |
Knoll Ag |
Arzneiformen mit gesteuerter Freisetzung, enthaltend gut wasserlösliche Wirkstoffe
|
EG23951A
(en)
|
1999-03-25 |
2008-01-29 |
Otsuka Pharma Co Ltd |
Cilostazol preparation
|
CN100370967C
(zh)
*
|
1999-06-04 |
2008-02-27 |
阿尔萨公司 |
埋植凝胶组合物及其制备方法
|
US6562375B1
(en)
|
1999-08-04 |
2003-05-13 |
Yamanouchi Pharmaceuticals, Co., Ltd. |
Stable pharmaceutical composition for oral use
|
JP4100910B2
(ja)
*
|
1999-12-23 |
2008-06-11 |
ファイザー・プロダクツ・インク |
ヒドロゲル駆動の薬物剤形
|
WO2001078681A1
(fr)
*
|
2000-04-17 |
2001-10-25 |
Yamanouchi Pharmaceutical Co., Ltd. |
Systeme d'administration de medicament empechant l'interaction pharmacocinetique entre les medicaments et procede correspondant
|
US20020028240A1
(en)
*
|
2000-04-17 |
2002-03-07 |
Toyohiro Sawada |
Timed-release compression-coated solid composition for oral administration
|
US6419954B1
(en)
|
2000-05-19 |
2002-07-16 |
Yamanouchi Pharmaceutical Co., Ltd. |
Tablets and methods for modified release of hydrophilic and other active agents
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
PE20030527A1
(es)
*
|
2001-10-24 |
2003-07-26 |
Gruenenthal Chemie |
Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
|
US20030091630A1
(en)
*
|
2001-10-25 |
2003-05-15 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
|
US20030152622A1
(en)
*
|
2001-10-25 |
2003-08-14 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral diuretic
|
PL374280A1
(en)
*
|
2001-11-13 |
2005-10-03 |
Yamanouchi Pharma Technologies, Inc. |
Soluble drug extended release system
|
EP1469832B2
(en)
*
|
2002-02-01 |
2016-10-26 |
Bend Research, Inc. |
Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials
|
AU2003211267A1
(en)
*
|
2002-02-27 |
2003-09-09 |
Shionogi And Co., Ltd. |
Solid preparations with improved absorbability of hardly water-soluble drug
|
NZ519363A
(en)
*
|
2002-06-05 |
2004-02-27 |
Agres Ltd |
A novel drug dosing regimen
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
MY142204A
(en)
|
2002-07-25 |
2010-10-29 |
Pharmacia Corp |
Pramipexole once-daily dosage form
|
EP1537880A4
(en)
|
2002-09-11 |
2009-07-01 |
Takeda Pharmaceutical |
PREPARATION FOR PROLONGED RELEASE
|
MY148805A
(en)
*
|
2002-10-16 |
2013-05-31 |
Takeda Pharmaceutical |
Controlled release preparation
|
JP4459543B2
(ja)
|
2003-03-17 |
2010-04-28 |
株式会社メドジェル |
徐放性ハイドロゲル製剤
|
CA2532931A1
(en)
*
|
2003-08-04 |
2005-02-10 |
Pfizer Products Inc. |
Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials
|
DE102005005446A1
(de)
*
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
DE102004020220A1
(de)
*
|
2004-04-22 |
2005-11-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
US8075872B2
(en)
|
2003-08-06 |
2011-12-13 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
US20070048228A1
(en)
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
DE102004032051A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
DE10361596A1
(de)
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
US8128958B2
(en)
|
2003-11-10 |
2012-03-06 |
Astellas Pharma Inc. |
Sustained release pharmaceutical composition
|
US8197846B2
(en)
*
|
2003-11-10 |
2012-06-12 |
Astellas Pharma Inc. |
Sustained release pharmaceutical composition
|
US20050171248A1
(en)
*
|
2004-02-02 |
2005-08-04 |
Yanmei Li |
Hydrogel for use in downhole seal applications
|
US20070196396A1
(en)
*
|
2004-02-11 |
2007-08-23 |
Rubicon Research Private Limited |
Controlled release pharmaceutical compositions with improved bioavailability
|
SI1765292T1
(en)
|
2004-06-12 |
2018-04-30 |
Collegium Pharmaceutical, Inc. |
Formulations of medicines to discourage abuse
|
DE102004032049A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
US7409999B2
(en)
*
|
2004-07-30 |
2008-08-12 |
Baker Hughes Incorporated |
Downhole inflow control device with shut-off feature
|
PL1789021T3
(pl)
|
2004-08-13 |
2012-04-30 |
Boehringer Ingelheim Int |
Preparat tabletkowy o przedłużonym uwalnianiu zawierający pramipeksol lub jego farmaceutycznie dopuszczalną sól
|
CA2576386A1
(en)
|
2004-08-13 |
2006-02-16 |
Boehringer Ingelheim International Gmbh |
Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
|
US20060074182A1
(en)
|
2004-09-30 |
2006-04-06 |
Depuy Products, Inc. |
Hydrogel composition and methods for making the same
|
WO2006038596A1
(ja)
*
|
2004-10-05 |
2006-04-13 |
Astellas Pharma Inc. |
涙液及び唾液乾燥症治療用医薬組成物
|
US20060128719A1
(en)
*
|
2004-12-13 |
2006-06-15 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Use of alpha-adrenergic blockers for the treatment of dysmenorrhea
|
DE102005005449A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
US20060239956A1
(en)
*
|
2005-04-26 |
2006-10-26 |
Lulu Henson |
Preparation and use of hydrogels
|
AU2006282506A1
(en)
*
|
2005-08-23 |
2007-03-01 |
Nissan Chemical Industries, Ltd. |
Sustained-release preparation
|
EP1946780B1
(en)
*
|
2005-11-11 |
2012-01-11 |
Asahi Kasei Chemicals Corporation |
Controlled release solid preparation
|
GB0607534D0
(en)
*
|
2006-04-13 |
2006-05-24 |
Univ London Pharmacy |
Colonic drug delivery formulation
|
EP2026766A1
(en)
|
2006-05-17 |
2009-02-25 |
Synthon B.V. |
Tablet composition with a prolonged release of tamsulosin
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
WO2008059792A1
(fr)
*
|
2006-11-13 |
2008-05-22 |
Kyorin Pharmaceutical Co., Ltd. |
Procédé de production d'un comprimé à libération prolongée
|
US20080221047A1
(en)
|
2006-12-27 |
2008-09-11 |
Astellas Pharma Inc., |
Aminoakyl methacrylate copolymer E for maintaining solubility of poorly-soluble drug
|
KR100885029B1
(ko)
*
|
2007-02-07 |
2009-02-23 |
지엘팜텍 주식회사 |
경구투여용 서방성 삼중정제
|
DE102007011485A1
(de)
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Darreichungsform mit erschwertem Missbrauch
|
US20090036414A1
(en)
*
|
2007-08-02 |
2009-02-05 |
Mutual Pharmaceutical Company, Inc. |
Mesalamine Formulations
|
US7942206B2
(en)
|
2007-10-12 |
2011-05-17 |
Baker Hughes Incorporated |
In-flow control device utilizing a water sensitive media
|
EP2047847A1
(en)
|
2007-10-12 |
2009-04-15 |
KRKA, tovarna zdravil, d.d., Novo mesto |
Solid pharmaceutical composition comprising tamsulosin
|
US8312931B2
(en)
|
2007-10-12 |
2012-11-20 |
Baker Hughes Incorporated |
Flow restriction device
|
US8096351B2
(en)
*
|
2007-10-19 |
2012-01-17 |
Baker Hughes Incorporated |
Water sensing adaptable in-flow control device and method of use
|
US7775271B2
(en)
|
2007-10-19 |
2010-08-17 |
Baker Hughes Incorporated |
Device and system for well completion and control and method for completing and controlling a well
|
US7784543B2
(en)
*
|
2007-10-19 |
2010-08-31 |
Baker Hughes Incorporated |
Device and system for well completion and control and method for completing and controlling a well
|
US20090101354A1
(en)
*
|
2007-10-19 |
2009-04-23 |
Baker Hughes Incorporated |
Water Sensing Devices and Methods Utilizing Same to Control Flow of Subsurface Fluids
|
US8544548B2
(en)
*
|
2007-10-19 |
2013-10-01 |
Baker Hughes Incorporated |
Water dissolvable materials for activating inflow control devices that control flow of subsurface fluids
|
US7793714B2
(en)
|
2007-10-19 |
2010-09-14 |
Baker Hughes Incorporated |
Device and system for well completion and control and method for completing and controlling a well
|
US7775277B2
(en)
*
|
2007-10-19 |
2010-08-17 |
Baker Hughes Incorporated |
Device and system for well completion and control and method for completing and controlling a well
|
US8069921B2
(en)
*
|
2007-10-19 |
2011-12-06 |
Baker Hughes Incorporated |
Adjustable flow control devices for use in hydrocarbon production
|
US7918272B2
(en)
*
|
2007-10-19 |
2011-04-05 |
Baker Hughes Incorporated |
Permeable medium flow control devices for use in hydrocarbon production
|
US7913765B2
(en)
*
|
2007-10-19 |
2011-03-29 |
Baker Hughes Incorporated |
Water absorbing or dissolving materials used as an in-flow control device and method of use
|
US7913755B2
(en)
|
2007-10-19 |
2011-03-29 |
Baker Hughes Incorporated |
Device and system for well completion and control and method for completing and controlling a well
|
US7789139B2
(en)
|
2007-10-19 |
2010-09-07 |
Baker Hughes Incorporated |
Device and system for well completion and control and method for completing and controlling a well
|
US7891430B2
(en)
|
2007-10-19 |
2011-02-22 |
Baker Hughes Incorporated |
Water control device using electromagnetics
|
US20090101344A1
(en)
*
|
2007-10-22 |
2009-04-23 |
Baker Hughes Incorporated |
Water Dissolvable Released Material Used as Inflow Control Device
|
US7918275B2
(en)
*
|
2007-11-27 |
2011-04-05 |
Baker Hughes Incorporated |
Water sensitive adaptive inflow control using couette flow to actuate a valve
|
BRPI0906467C1
(pt)
|
2008-01-25 |
2021-05-25 |
Gruenenthal Gmbh |
forma de dosagem farmacêutica com formato exterior modificado resistente à ruptura e com liberação controlada
|
US7597150B2
(en)
|
2008-02-01 |
2009-10-06 |
Baker Hughes Incorporated |
Water sensitive adaptive inflow control using cavitations to actuate a valve
|
US8839849B2
(en)
*
|
2008-03-18 |
2014-09-23 |
Baker Hughes Incorporated |
Water sensitive variable counterweight device driven by osmosis
|
US7992637B2
(en)
*
|
2008-04-02 |
2011-08-09 |
Baker Hughes Incorporated |
Reverse flow in-flow control device
|
DE102008022520A1
(de)
*
|
2008-05-07 |
2009-11-12 |
Bayer Animal Health Gmbh |
Feste Arzneimittelformulierung mit verzögerter Freisetzung
|
US8931570B2
(en)
*
|
2008-05-08 |
2015-01-13 |
Baker Hughes Incorporated |
Reactive in-flow control device for subterranean wellbores
|
KR101690094B1
(ko)
|
2008-05-09 |
2016-12-27 |
그뤼넨탈 게엠베하 |
분무 응결 단계의 사용하에 중간 분말 제형 및 최종 고체 제형을 제조하는 방법
|
US8171999B2
(en)
*
|
2008-05-13 |
2012-05-08 |
Baker Huges Incorporated |
Downhole flow control device and method
|
US8113292B2
(en)
|
2008-05-13 |
2012-02-14 |
Baker Hughes Incorporated |
Strokable liner hanger and method
|
US7789152B2
(en)
|
2008-05-13 |
2010-09-07 |
Baker Hughes Incorporated |
Plug protection system and method
|
US8555958B2
(en)
|
2008-05-13 |
2013-10-15 |
Baker Hughes Incorporated |
Pipeless steam assisted gravity drainage system and method
|
US7762341B2
(en)
*
|
2008-05-13 |
2010-07-27 |
Baker Hughes Incorporated |
Flow control device utilizing a reactive media
|
EP2161019A1
(en)
|
2008-09-05 |
2010-03-10 |
KRKA, D.D., Novo Mesto |
Prolonged release multiparticulate pharmaceutical composition comprising paliperidone
|
TWI478712B
(zh)
*
|
2008-09-30 |
2015-04-01 |
Astellas Pharma Inc |
釋控性醫藥組成物
|
US8465770B2
(en)
|
2008-12-24 |
2013-06-18 |
Synthon Bv |
Low dose controlled release tablet
|
NZ594311A
(en)
*
|
2009-02-04 |
2013-05-31 |
Astellas Pharma Inc |
Pharmaceutical composition comprising tamsulosin and solifenacin for oral administration
|
EP2255793A1
(en)
|
2009-05-28 |
2010-12-01 |
Krka Tovarna Zdravil, D.D., Novo Mesto |
Pharmaceutical composition comprising tamsulosin
|
US8151881B2
(en)
*
|
2009-06-02 |
2012-04-10 |
Baker Hughes Incorporated |
Permeability flow balancing within integral screen joints
|
US20100300675A1
(en)
*
|
2009-06-02 |
2010-12-02 |
Baker Hughes Incorporated |
Permeability flow balancing within integral screen joints
|
US20100300674A1
(en)
*
|
2009-06-02 |
2010-12-02 |
Baker Hughes Incorporated |
Permeability flow balancing within integral screen joints
|
US8056627B2
(en)
*
|
2009-06-02 |
2011-11-15 |
Baker Hughes Incorporated |
Permeability flow balancing within integral screen joints and method
|
US8132624B2
(en)
*
|
2009-06-02 |
2012-03-13 |
Baker Hughes Incorporated |
Permeability flow balancing within integral screen joints and method
|
WO2011009604A1
(en)
|
2009-07-22 |
2011-01-27 |
Grünenthal GmbH |
Oxidation-stabilized tamper-resistant dosage form
|
PE20121067A1
(es)
|
2009-07-22 |
2012-09-05 |
Gruenenthal Chemie |
Forma de dosificacion de liberacion controlada extruida por fusion en caliente
|
CA2780274C
(en)
|
2009-11-09 |
2018-06-26 |
Spotlight Technology Partners Llc |
Fragmented hydrogels
|
CA2780294C
(en)
|
2009-11-09 |
2018-01-16 |
Spotlight Technology Partners Llc |
Polysaccharide based hydrogels
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
ES2606227T3
(es)
|
2010-02-03 |
2017-03-23 |
Grünenthal GmbH |
Preparación de una composición farmacéutica en polvo mediante una extrusora
|
CN104224737A
(zh)
*
|
2010-02-24 |
2014-12-24 |
硕腾有限责任公司 |
兽医组合物
|
WO2011122523A1
(ja)
*
|
2010-03-29 |
2011-10-06 |
アステラス製薬株式会社 |
放出制御医薬組成物
|
US20120070465A1
(en)
|
2010-03-29 |
2012-03-22 |
Astellas Pharma Inc. |
Pharmaceutical composition for modified release
|
WO2012028319A1
(en)
|
2010-09-02 |
2012-03-08 |
Grünenthal GmbH |
Tamper resistant dosage form comprising inorganic salt
|
CA2808541C
(en)
|
2010-09-02 |
2019-01-08 |
Gruenenthal Gmbh |
Tamper resistant dosage form comprising an anionic polymer
|
US9011912B2
(en)
|
2010-10-07 |
2015-04-21 |
Abon Pharmaceuticals, Llc |
Extended-release oral dosage forms for poorly soluble amine drugs
|
SG191288A1
(en)
|
2010-12-22 |
2013-07-31 |
Purdue Pharma Lp |
Encased tamper resistant controlled release dosage forms
|
JP5638151B2
(ja)
|
2010-12-23 |
2014-12-10 |
パーデュー、ファーマ、リミテッド、パートナーシップ |
不正加工抵抗性の(tamperresistant)固形経口剤形
|
KR102027912B1
(ko)
|
2011-02-15 |
2019-10-02 |
지엘팜텍주식회사 |
경구투여용 탐술로신 또는 이의 약제학적으로 허용되는 염을 포함하는 서방성 삼중정제
|
RU2451680C1
(ru)
|
2011-02-21 |
2012-05-27 |
Общество С Ограниченной Ответственностью "Научно-Исследовательская Компания "Медбиофарм" |
Клатратный комплекс циклодекстрина или арабиногалактана с 9-фенил-симм-октагидроселеноксантеном, способ его получения (варианты), фармацевтическая композиция и лекарственное средство
|
CN103917092B
(zh)
*
|
2011-06-07 |
2018-04-24 |
珍尔希斯股份有限公司 |
生产水凝胶的方法
|
KR20140053158A
(ko)
|
2011-07-29 |
2014-05-07 |
그뤼넨탈 게엠베하 |
즉시 약물 방출을 제공하는 탬퍼-저항성 정제
|
AR087360A1
(es)
|
2011-07-29 |
2014-03-19 |
Gruenenthal Gmbh |
Tableta a prueba de manipulacion que proporciona liberacion de farmaco inmediato
|
AU2012326976B2
(en)
|
2011-10-21 |
2017-08-17 |
Takeda Pharmaceutical Company Limited |
Sustained-release preparation
|
US20130143867A1
(en)
|
2011-12-02 |
2013-06-06 |
Sychroneuron Inc. |
Acamprosate formulations, methods of using the same, and combinations comprising the same
|
CA2864949A1
(en)
|
2012-02-28 |
2013-09-06 |
Grunenthal Gmbh |
Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
|
JP6123795B2
(ja)
*
|
2012-03-30 |
2017-05-10 |
アステラス製薬株式会社 |
放出制御医薬組成物
|
JP6282261B2
(ja)
|
2012-04-18 |
2018-02-21 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
不正使用防止および過量放出防止医薬剤形
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
WO2014096181A1
(en)
*
|
2012-12-21 |
2014-06-26 |
Nestec S.A. |
Device for producing milk foam
|
US8999393B1
(en)
|
2013-01-09 |
2015-04-07 |
Edgemont Pharmaceuticals Llc |
Sustained release formulations of lorazepam
|
US9149533B2
(en)
|
2013-02-05 |
2015-10-06 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
CA2913209A1
(en)
|
2013-05-29 |
2014-12-04 |
Grunenthal Gmbh |
Tamper resistant dosage form with bimodal release profile
|
EP3003279A1
(en)
|
2013-05-29 |
2016-04-13 |
Grünenthal GmbH |
Tamper-resistant dosage form containing one or more particles
|
JP2016520653A
(ja)
|
2013-06-05 |
2016-07-14 |
シンクロニューロン インコーポレイテッド |
アカンプロサート製剤、それを用いる方法、およびそれを含む合剤
|
AU2014289187B2
(en)
|
2013-07-12 |
2019-07-11 |
Grunenthal Gmbh |
Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
|
MX371372B
(es)
|
2013-11-26 |
2020-01-28 |
Gruenenthal Gmbh |
Preparacion de una composicion farmaceutica en polvo por medio de criomolienda.
|
CA2947786A1
(en)
|
2014-05-12 |
2015-11-19 |
Grunenthal Gmbh |
Tamper resistant immediate release capsule formulation comprising tapentadol
|
WO2015181059A1
(en)
|
2014-05-26 |
2015-12-03 |
Grünenthal GmbH |
Multiparticles safeguarded against ethanolic dose-dumping
|
CN115381850A
(zh)
|
2014-06-20 |
2022-11-25 |
吉莱斯公司 |
用于治疗超重或肥胖症的方法
|
EA036036B1
(ru)
|
2014-11-07 |
2020-09-16 |
Сигмойд Фарма Лимитед |
Композиции, содержащие циклоспорин
|
EP3250612B1
(en)
|
2015-01-29 |
2020-12-02 |
Gelesis LLC |
Method for producing hydrogels coupling high elastic modulus and absorbance
|
US20190125678A1
(en)
|
2015-01-30 |
2019-05-02 |
Mylan, Inc. |
Sustained-Release Oral Dosage Forms for Low Aqueous Solubility Compounds
|
JP2018517676A
(ja)
|
2015-04-24 |
2018-07-05 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
即時放出および溶媒抽出に対する耐性を有する改変防止製剤
|
TWI722988B
(zh)
*
|
2015-06-05 |
2021-04-01 |
瑩碩生技醫藥股份有限公司 |
緩釋性醫藥組合物及其製備方法
|
WO2017042325A1
(en)
|
2015-09-10 |
2017-03-16 |
Grünenthal GmbH |
Protecting oral overdose with abuse deterrent immediate release formulations
|
US9687475B1
(en)
|
2016-03-24 |
2017-06-27 |
Ezra Pharma Llc |
Extended release pharmaceutical formulations with controlled impurity levels
|
US9675585B1
(en)
|
2016-03-24 |
2017-06-13 |
Ezra Pharma |
Extended release pharmaceutical formulations
|
CN105770866A
(zh)
*
|
2016-04-08 |
2016-07-20 |
王夕花 |
一种缓释型降糖药物组合物及其制备方法
|
US10543174B2
(en)
|
2016-04-25 |
2020-01-28 |
Synthon B.V. |
Modified release tablet composition comprising mirabegron
|
RU2745992C2
(ru)
|
2016-04-25 |
2021-04-05 |
Джелесис ЭлЭлСи |
Способ лечения запора
|
US20190307696A1
(en)
|
2016-04-25 |
2019-10-10 |
Synthon B.V. |
Tablets comprising mirabegron and solifenacin
|
US9737530B1
(en)
|
2016-06-23 |
2017-08-22 |
Collegium Pharmaceutical, Inc. |
Process of making stable abuse-deterrent oral formulations
|
WO2019072404A1
(en)
|
2017-10-12 |
2019-04-18 |
Synthon B.V. |
MODIFIED RELEASE COMPRESSED COMPOSITION COMPRISING MIRABEGRON
|
US10478399B2
(en)
|
2017-10-12 |
2019-11-19 |
Synthon B.V. |
Modified release tablet composition comprising mirabegron
|
EP3292864A1
(en)
|
2017-10-12 |
2018-03-14 |
Synthon B.V. |
Modified release tablet composition comprising mirabegron
|
ES2963886T3
(es)
|
2017-10-17 |
2024-04-03 |
Synthon Bv |
Comprimidos que contienen tamsulosina y solifenacina
|
WO2021153716A1
(en)
*
|
2020-01-31 |
2021-08-05 |
Nippon Shinyaku Co., Ltd. |
Controlled release composition
|
CN111728949B
(zh)
*
|
2020-07-17 |
2022-10-04 |
广州帝奇医药技术有限公司 |
一种难溶性药物口服缓释组合物及其制备方法
|
WO2022117594A1
(en)
|
2020-12-01 |
2022-06-09 |
Adamed Pharma S.A. |
Orally-administered preparation containing solifenacin and tamsulosin
|
SI4037666T1
(sl)
|
2020-12-08 |
2024-09-30 |
Ruminant Biotech Corp Limited |
Izboljšave naprav in postopkov za dostavo snovi živalim
|
US12097189B1
(en)
|
2024-02-09 |
2024-09-24 |
Astellas Pharma Inc. |
Pharmaceutical composition for modified release
|